Introduction
============

Diffuse pulmonary ossification (DPO) is a rare disease characterized by the ectopic formation of mature bone in the bilateral lung parenchyma. This disease was first reported by Luschka in 1856 ([@B1]). There are few cases in which living patients are diagnosed with DPO, as the symptoms are generally subclinical, and radiographical abnormalities are usually masked by other pulmonary diseases. According to autopsy data, the incidence of DPO ranges from 0.16% to 1.6% ([@B2]-[@B4]).

DPO can be classified into two subtypes: nodular and dendriform DPO, both of which have secondary and idiopathic forms ([@B2], [@B5]). Most cases of dendriform DPO arise secondary to acute or chronic damage of the lung, such as idiopathic pulmonary fibrosis, acute respiratory distress syndrome, and chronic obstructive pulmonary disease ([@B6]). In contrast, idiopathic DPO is extremely rare: to our knowledge, only around 20 cases have been reported, even including possible cases ([@B5], [@B7]-[@B21]). Few of these reports included detailed pulmonary function data, and even the reports with available data showed inconsistent results. Among them, only one report presented the long-term follow-up data ([@B10]). In that case report, the lung volumes and diffusing capacity of the lung for carbon monoxide (D~LCO~) declined slightly over 14 years (detailed data were lacking), suggesting that idiopathic dendriform DPO may progress very slowly.

We herein report a case of idiopathic dendriform DPO that progressed over 11 years and resulted in severe restrictive ventilatory impairment.

Case Report
===========

The patient was a 47-year old man (height, 172.9 cm; weight, 75.6 kg). He was admitted with spontaneous pneumothorax at 27 years of age. His pneumothorax was cured by chest drainage, but chest X-ray and computed tomography (CT) revealed bilateral diffuse nodular opacities. A transbronchial lung biopsy was performed, but a definitive diagnosis could not be reached.

He presented to the hospital again with diffuse nodular opacities at 30 years of age. A video-assisted thoracoscopic lung biopsy of the right lobe was performed. Multiple dendric foci of bone were observed in the alveolar spaces ([Fig. 1](#g001){ref-type="fig"}). The histopathological image showed subpleural fibrosis, predominantly around the ossified areas, but it was not specific. There were no findings of interstitial lung disease associated with these lesions. Other underlying heart and pulmonary diseases were excluded, so he was diagnosed with idiopathic dendriform DPO. He had a history of hypertension. He had been a smoker from age 16 and quit smoking at age 45 (29 pack-years). He had been working as a plumber from 26 years of age and then started working in industrial waste disposal at 43 years of age, wearing a dust mask. Regarding his family medical history, his mother has been diagnosed with pulmonary calcification.

![A surgical lung biopsy specimen shows multiple bone formations in the alveolar spaces (arrows).](1349-7235-57-1631-g001){#g001}

The images of chest X-ray and CT at 33 years of age are shown in [Fig. 2A-C](#g002){ref-type="fig"}. Chest X-ray showed bilateral ground-glass opacity, and CT revealed high-density nodules bilaterally in the lower lobes. Despite the abnormal chest images, the pulmonary function test conducted at 36 years of age showed normal results ([Table 1](#t001){ref-type="table"}): the vital capacity (VC) was 3.39 L (82.4% predicted), and the forced expiratory volume in 1 second/forced vital capacity ratio (FEV~1~/FVC) was 81.9%.

![Chest X-ray (A), CT image with lung window (B), and CT image with bone window (C) at 33 years of age. Chest X-ray (D), CT image with lung window (E), and CT image with bone window (F) at 46 years of age. Chest X-ray showed bilateral ground-glass opacity, and CT showed high-density nodules bilaterally in the lower lobes. Compared with the images at 33 years of age, the bilateral ground-glass opacity on chest X-ray had progressed, and the number of high-density nodules on CT had increased significantly at 46 years of age.](1349-7235-57-1631-g002){#g002}

###### 

Pulmonary Function Data at Ages 36 and 47 Years.

                               Age: 36           Age: 47           
  ------------ --------------- --------- ------- --------- ------- ------
  VC           \(L\)           3.39      82.4              1.98    44.6
  FVC          \(L\)           3.20      77.8              1.92    44.1
  FEV~1~       \(L\)           2.62      68.9              1.58    42.4
  FEV~1~/FVC   (%)             81.87     104.4             82.29   96.6
  D~LCO~       (mL/min/mmHg)   N/A       N/A               15.39   53.8
  RV/TLC       (%)             N/A       \-                45.58   \-

VC: vital capacity, FVC: forced vital capacity, FEV~1~: forced expiratory volume in 1 second, D~LCO~: diffusing capacity of the lung for carbon monoxide, RV: residual volume, TLC: total lung capacity, N/A: not available

He visited the hospital again at 46 years of age after a 10-year interval due to cough and dyspnea when climbing stairs. The laboratory data showed no abnormal results, except for elevation of Krebs von den Lungen (KL)-6 (870 U/mL) ([Table 2](#t002){ref-type="table"}). Echocardiogram also showed no abnormalities. Chest X-ray revealed the progression of bilateral ground-glass opacity ([Fig. 2D](#g002){ref-type="fig"}). The number of high-density nodules had increased significantly in lower lobes ([Fig. 2E, F](#g002){ref-type="fig"}). Pulmonary function tests revealed that the VC had decreased severely (1.98 L, 44.6% predicted) ([Table 1](#t001){ref-type="table"}), while the FEV~1~/FVC was 82.3% (96.6% predicted). The D~LCO~ was decreased (15.4 mL/min/mmHg, 53.8% predicted), and the residual volume/total lung capacity ratio (RV/TLC) was increased (45.58%). Given these data, we diagnosed the patient with severe restrictive ventilatory impairment due to the progression of DPO. Because there is no established medical treatment, he is now being evaluated for listing for lung transplantation.

###### 

Laboratory Data at Age 46 Years.

  ------------- ------------- -------------- -- ------------ ------- ----------------- -- -------------------------- -------- --------
  Hematology                  Biochemistry      Immunology                                                                    
  WBC           9.77×10^9^    /L                AST          22      U/L                  PR3-ANCA                   \<1.0    U/mL
  Neutrophil    54.1          \%                ALT          15      U/L                  MPO-ANCA                   \<1.0    U/mL
  Lymphocyte    31.9          \%                LDH          200     U/L                  KL-6                       870      U/mL
  Monocyte      7.4           \%                ALP          289     U/L                  Anti-ds DNA antibody       \<7      IU/mL
  Eosinophil    5.9           \%                γ-GTP        28      U/L                  Anti-centromere antibody   \<5.0    
  Basophil      0.7           \%                TP           7.2     g/dL                 Anti-nuclear antibody      \<1:40   
  RBC           4.99×10^12^   /L                ALB          4.2     g/dL                 SP-D                       96.1     ng/mL
  HGB           15.3          g/dL              Ch-E         407     U/L                  Anti-CCP antibody          \<0.6    U/mL
  HCT           45.8          \%                T-Bil        0.5     mg/dL                Anti-ARS antibody          \<5.0    U/mL
  MCV           91.8          fL                CRE          0.83    mg/dL                Anti-Sm antibody           \<5.0    U/mL
  MCH           30.7          pg                eGFR         79.3    mL/min/1.73m^2^      Anti-RNP antibody          \<5.0    U/mL
  MCHC          33.4          \%                UA           6.3     mg/dL                Anti-SS-A antibody         \<5.0    U/mL
  PLT           306×10^9^     /L                BUN          10      mg/dL                Anti-SS-B antibody         \<5.0    U/mL
                                                T-CHO        199     mg/dL                Anti-Scl-70 antibody       \<5.0    U/mL
  Coagulation                                   TG           54      mg/dL                                                    
  PT            11.4          s                 CK           147     U/L                  Blood gas analysis                  
  PT-INR        0.99                            Na           140     mEq/L                pH                         7.37     
  APTT          43.5          s                 K            4.1     mEq/L                PaO~2~                     91.1     Torr
  Fibrinogen    328           mg/dL             Cl           106     mEq/L                PaCO~2~                    40.5     Torr
                                                Ca           9.5     mg/dL                HCO~3~^-^                  23       mmol/L
                                                IP           2.7     mg/dL                BE                         -2.0     mmol/L
                                                CRP          \<0.1   mg/dL                                                    
                                                ACE          12.4    U/L                  6-min walking distance     555      m
                                                Aldolase     6       U/L                                                      
  ------------- ------------- -------------- -- ------------ ------- ----------------- -- -------------------------- -------- --------

WBC: white blood cell, RBC: red blood cell, HGB: hemoglobin, HCT: hematocrit, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, PT: prothrombin time, PT-INR: prothrombin time international normalized ratio, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, ALT: alanine aminotransferase, LDH: lactate dehydrogenase, ALP: alkaline phosphatase, γ-GTP: gamma glutamyl transpeptidase, TP: total protein, ALB: albumin, Ch-E: cholinesterase, T-Bil: total bilirubin, CRE: creatinine, eGFR: epidermal growth factor receptor, UA: uric acid, BUN: blood urea nitrogen, T-CHO: total cholesterol, TG: triglycerides, CK: creatine kinase, Na: sodium, K: potassium, Cl: chloride, Ca: calcium, IP: inorganic phosphorus, CRP: C-reactive protein, ACE: angiotensin-1-converting enzyme, PR3: proteinase3, ANCA: anti neutrophil cytoplasmic antibody, MPO: myeloperoxidase, KL-6: Krebs von den Lungen-6, SP-D: surfactant protein-D, CCP: cyclic citrullinated peptide, ARS: aminoacyl tRNA synthetase, Sm: Smith, RNP: ribonucleoprotein, SS-A: Sjögren syndrome-A, SS-B: Sjögren syndrome-B, BE: base excess

Discussion
==========

We encountered a case of idiopathic DPO. Secondary DPO can be derived from not only preexisting disorders but also rare earth metal and heavy metal exposure ([@B22], [@B23]). This patient has an occupational history as a plumber before the diagnosis. The association between his occupation as a plumber and the pathogenesis of DPO is not apparent, as the exposure period until the episode of spontaneous pneumothorax was only one year. We summarized the published cases of idiopathic DPO in [Table 3](#t003){ref-type="table"}. Some reports have shown that spontaneous pneumothorax can be caused by pulmonary ossification ([@B14], [@B18]-[@B20]); therefore, DPO might have been present when our patient suffered from spontaneous pneumothorax. Based on the published cases, idiopathic DPO appears to occur predominantly in younger man, which is compatible with our case.

###### 

Summary of the Published Cases of Idiopathic Diffuse Pulmonary Ossification.

  Case No.   Age, years   Sex   Past medical history                                                                   Family history                                                                   Smoking history   Environmental / occupational exposures                                                                                      Pulmonary function test, % predicted                                                 Reference No.
  ---------- ------------ ----- -------------------------------------------------------------------------------------- -------------------------------------------------------------------------------- ----------------- --------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ---------------
  1          34           M     Intermittent hemoptysis                                                                Not mentioned                                                                    10 pack-years     Never                                                                                                                       FVC: 109%, FEV~1~: 87%, D~LCO~: 72%                                                  5
  2          29           M     Pneumothorax                                                                           Father: Dendriform pulmonary ossification                                        Not mentioned     Not mentioned                                                                                                               Not mentioned                                                                        9
  3          43           M     Allergic rhinitis/ Asthma/ Diabetes mellitus/ Coronary atherosclerotic heart disease   Not mentioned                                                                    Never             Never                                                                                                                       \"Lung volumes and D~LCO~ have declined slightly over 14 years\"                     10
  4          51           M     None                                                                                   Not mentioned                                                                    Not mentioned     Never                                                                                                                       \"Normal except for an isolated reduction in the transfer factor (73% predicted)\"   11
  5          26           M     Cleft lip and palate/ Chronic sinusitis                                                None                                                                             Never             Never                                                                                                                       \"Normal\"                                                                           12
  6          32           M     Pneumonia                                                                              Not mentioned                                                                    Never             Never                                                                                                                       VC: 93%, FVC: 82%, FEV~1~: 71%, D~LCO~: 102%                                         13
  7          47           M     Pneumothorax                                                                           Not mentioned                                                                    Not mentioned     Exposure to methylmethacrylate, quartz cristobalite, chrome cobalt, alginates, asbestos and silica as a dental technician   \"Normal\"                                                                           14
  8          49           M     None                                                                                   Not mentioned                                                                    Never             Not mentioned                                                                                                               \"A slow and progressive decline in pulmonary function\"                             15
  9          58           M     Left renal artery stenosis/ Ischemic stroke                                            Not mentioned                                                                    Not mentioned     Never                                                                                                                       Not mentioned                                                                        16
  10         43           M     None                                                                                   Not mentioned                                                                    Never             Never                                                                                                                       VC: 110%, FVC: 99%, FEV~1~: 92%, D~LCO~: 71%                                         17
  11         33           M     Pneumothorax/ Asthma                                                                   Not mentioned                                                                    Never             Not mentioned                                                                                                               Not mentioned                                                                        18
  12         53           M     Pneumothorax                                                                           Not mentioned                                                                    Not mentioned     Not mentioned                                                                                                               Not mentioned                                                                        19
  13         26           M     Pneumothorax                                                                           Father: Similar lung condition in his 30s with computed tomography (CT) images   Never             Never                                                                                                                       \"Normal\" (FEV~1~: 91%)                                                             20
  14         47           F     Hypoplasia and deformity of the middle fingers/ Diabetes mellitus/ Schizophrenia       Father: Multiple small high density nodules by CT                                Never             Never                                                                                                                       VC: 101%, FEV~1~: 71%                                                                21

In addition to the case with \"idiopathic\" in the publication, the possible cases were included. Some old publications which have only abstracts with little information of the cases on the PubMed were excluded. Not mentioned: No available information in the publication, VC: vital capacity, FVC: forced vital capacity, FEV~1~: forced expiratory volume in one second, D~LCO~: diffusing capacity of the lung for carbon monoxide

Idiopathic dendriform DPO has been thought to be an indolent condition ([@B5], [@B10]). Our patient\'s VC decreased approximately 1.4 L (41.6% of the predicted VC at 36 years of age) over 11 years, which is the most severe case on record of idiopathic dendriform DPO. Although the decreased lung volume based on the images and the decreased D~LCO~ along with the VC suggest the progression of fibrosis, there were no apparent findings of interstitial pneumonia by CT. Based on the histological and radiological findings, we speculate that the non-specific lung fibrosis did not precede ossification but developed secondary to ossification. However, its mechanism remains unclear. During the video-assisted thoracoscopic lung biopsy, the lung showed incomplete collapse, suggesting that lung compliance was decreased. Our patient\'s chest CT image showed abundant high-density nodules bilaterally compared with the literature cases ([@B5], [@B11], [@B14], [@B17]). This result may explain the severity of the restrictive ventilatory impairment in our case. The pulmonary function test also showed an impaired diffusing capacity (D~LCO~), which is compatible with the previous case ([@B10]).

Some biological hypotheses of DPO pathogenesis have been proposed. DPO is strongly associated with fibrosing interstitial lung diseases ([@B24]); however, the pathogenesis of idiopathic DPO is still uncertain. As a candidate, transforming growth factor-beta (TGF-β)/bone morphogenetic protein (BMP) is known to be associated with ectopic bone formation, as well as normal bone organogenesis ([@B25]). Furthermore, three reports of familial DPO have been published ([@B9], [@B20], [@B21]). Interestingly, two of these reports are from Japan. In all three cases, the patients\' fathers suffered from DPO. Some genetic abnormalities may be involved in DPO pathogenesis; therefore, when a patient is diagnosed with idiopathic DPO, the patient\'s family should also be checked, especially male relatives. We examined the present patient\'s mother, who had been diagnosed with pulmonary calcification, but her chest CT image showed only mild calcification, suggesting old inflammatory change. Unfortunately, we have no data for the patient\'s father or son at present.

In this case, the follow-up period from the first diagnosis was approximately 17 years, which is the longest period yet among such reports. However, it should be noted that whether the restrictive ventilatory impairment progressed gradually through the entire period or progressed rapidly in recent years is unknown, as the patient had missed appointments for approximately 10 years. In a previous report, lung transplantation was performed for end-stage pulmonary fibrosis, and the patient was diagnosed with DPO based on an examination of the extirpated lung ([@B26]); however, the prognosis after the transplantation is unknown. Further reports of idiopathic dendriform DPO with long-term follow-up data are required to determine the optimum timing for lung transplantation.
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